journal article·2017-06-26Open access

Synergy of Iron Chelators and Therapeutic Peptide Sequences Delivered via a Magnetic Nanocarrier

Gayani S. Abayaweera, Hongwang Wang, Tej B. Shrestha, Jing Yu, Kyle Angle, Prem Thapa, Aruni P. Malalasekera, Leila Maurmann, Deryl L. Troyer, Stefan H. Bossmann

Abstract

Here, we report the synthesis, characterization, and efficacy study of Fe/Fe3O4-nanoparticles that were co-labeled with a tumor-homing and membrane-disrupting oligopeptide and the iron-chelator Dp44mT, which belongs to the group of the thiosemicarbazones. Dp44mT and the peptide sequence PLFAERL(D[KLAKLAKKLAKLAK])CGKRK were tethered to the surface of Fe/Fe3O4 core/shell nanoparticles by utilizing dopamine-anchors. The 26-mer contains two important sequences, which are the tumor targeting peptide CGKRK, and D[KLAKLAK]2, known to disrupt the mitochondrial cell walls and to initiate programmed cell death (apoptosis). It is noteworthy that Fe/Fe3O4 nanoparticles can also be used for MRI imaging purposes in live mammals. In a first step of this endeavor, the efficacy of this nanoplatform has been tested on the highly metastatic 4T1 breast cancer cell line. At the optimal ratio of PLFAERD[KLAKLAK]2CGKRK to Dp44mT of 1 to 3.2 at the surface of the dopamine-coated Fe/Fe3O4-nanocarrier, the IC50 value after 24 h of incubation was found to be 2.2 times lower for murine breast cancer cells (4T1) than for a murine fibroblast cell line used as control. Based on these encouraging results, the reported approach has the potential of leading to a new generation of nanoplatforms for cancer treatment with considerably enhanced selectivity towards tumor cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Chemical Synthesis and Analysis · Peptidase Inhibition and Analysis · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Kansas State University, Manhattan, KS 66041, USA

tbs3@ksu.edu (T.B.S.)

Microscopy and Analytical Imaging Laboratory, University of Kansas, Lawrence, KS 66045, USA

Funding

National Science Foundation · Johnson Cancer Center

References (26)

Show source-provided references
1. Cancer Statistics, 201710.3322/caac.21387 ↗
2. Design of a Tumor-Homing Cell-Penetrating Peptide10.1021/bc0701139 ↗
3. Potent Retro-Inverso d-Peptide for Simultaneous Targeting of Angiogenic Blood Vasculature and Tumor Cells10.1021/bc300537z ↗
4. To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?10.1016/j.jconrel.2016.11.015 ↗
5. Bossmann, S.H., and Wang, H. (2017). Magnetic Nanoformulations for Enhanced Drug Delivery and Retention. Magnetic Nanomaterials: Applications in Catalysis and Life Sciences, The Royal Society of Chemistry.
6. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma10.1073/pnas.1114518108 ↗
7. Anti-cancer activity of targeted pro-apoptotic peptides10.1038/12469 ↗
8. Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma10.1016/S1535-6108(03)00273-3 ↗
9. The Iron Chelator Dp44mT Causes DNA Damage and Selective Inhibition of Topoisomerase IIα in Breast Cancer Cells10.1158/0008-5472.CAN-08-1437 ↗
10. The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: An EPR study10.1016/j.jinorgbio.2010.07.012 ↗
11. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells10.1016/j.bbamcr.2016.09.011 ↗
12. Mechanism of the induction of endoplasmic reticulum stress by the anti-cancer agent, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT): Activation of PERK/eIF2α, IRE1α, ATF6 and calmodulin kinase10.1016/j.bcp.2016.04.001 ↗
13. Enhanced targeting of mitochondrial peroxide defense by the combined use of thiosemicarbazones and inhibitors of thioredoxin reductase10.1016/j.freeradbiomed.2015.12.008 ↗
14. Determination of Peptide Substrate Specificity for μ-Calpain by a Peptide Library-based Approach: the importance of primed side interactions10.1074/jbc.M506870200 ↗
15. Attenuation of Mouse Melanoma by A/C Magnetic Field after Delivery of Bi-Magnetic Nanoparticles by Neural Progenitor Cells10.1021/nn100870z ↗
16. Balivada, S., Rachakatla, R.S., Wang, H., Samarakoon, T.N., Dani, R.K., Pyle, M., Kroh, F.O., Walker, B., Leaym, X., and Koper, O.B. (2010). A/C magnetic hyperthermia of melanoma mediated by iron(0)/iron oxide core/shell magnetic nanoparticles: A mouse study. BMC Cancer, 10.10.1186/1471-2407-10-119 ↗
17. Magnetic-Fe/Fe3O4-nanoparticle-bound SN38 as carboxylesterase-cleavable prodrug for the delivery to tumors within monocytes/macrophages10.3762/bjnano.3.51 ↗
18. Nanoplatforms for highly sensitive fluorescence detection of cancer-related proteases10.1039/c3pp50260k ↗
19. Early breast cancer screening using iron/iron oxide-based nanoplatforms with sub-femtomolar limits of detection10.3762/bjnano.7.33 ↗
20. Redox cycling metals: Pedaling their roles in metabolism and their use in the development of novel therapeutics10.1016/j.bbamcr.2016.01.026 ↗
21. Iron and cancer: recent insights10.1111/nyas.13008 ↗
22. Dopamine as A Robust Anchor to Immobilize Functional Molecules on the Iron Oxide Shell of Magnetic Nanoparticles10.1021/ja0464802 ↗
23. Nanoparticles in magnetic resonance imaging: From simple to dual contrast agents
24. Heterocyclic dithiocarbazate iron chelators: Fe coordination chemistry and biological activity10.1039/c2dt12387h ↗
25. Peptide Coupling Reagents, More than a Letter Soup10.1021/cr100048w ↗
26. Sitaampalam, G.S. (2004). Assay Guidance Manual.